Alibaba
US.BABA
113.24
+1.43
+1.28%
Alibaba
113.24
+1.43
+1.28%
Collector offline (last heartbeat: 19083s ago)
· 2026-09-04 20:02
Pre-market
112.33
+0.46%
After-hours
113.18
-0.05%
Overnight
112.48
+0.60%
Revenue annual, last 8 years
Latest year +2.74% YoY
Margins
- Gross margin
- 39.81%
- Operating margin
- 5.83%
- Net margin
- 10.35%
Key ratios & quality
- Enterprise value
- 228.89B
- PEG ratio
- 2.05
- Altman Z-Score
- 1.46
PEG uses trailing P/E against the 3-year net income growth rate (12.49%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.46, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 376.84B | 509.71B | 717.29B | 853.06B | 868.69B | 941.17B | 996.35B | 1.02T |
| Gross profit | 169.92B | 227.34B | 296.08B | 313.61B | 318.99B | 354.85B | 398.06B | 407.53B |
| Selling & admin expenses | 64.67B | 78.87B | 136.74B | 151.72B | 145.68B | 157.13B | 188.26B | 278.11B |
| Research & development | 37.44B | 43.08B | 57.24B | 55.47B | 56.74B | 52.26B | 57.15B | 66.53B |
| Operating profit | 57.08B | 92.01B | 89.68B | 94.78B | 103.07B | 123.87B | 147.08B | 59.67B |
| Pretax profit | 96.22B | 166.65B | 165.58B | 59.55B | 89.19B | 101.60B | 155.46B | 129.39B |
| Tax | 16.55B | 20.56B | 29.28B | 26.82B | 15.55B | 22.53B | 35.45B | 30.05B |
| Net profit | 80.23B | 140.35B | 143.28B | 47.08B | 65.57B | 71.33B | 125.98B | 102.13B |
| Basic EPS | 34 | 57 | 56 | 23 | 28 | 32 | 55 | 46 |
| Diluted EPS | 33.36 | 55.92 | 54.72 | 22.72 | 27.44 | 31.28 | 53.60 | 44.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 236.45B | 247.65B | 247.80B | 284.84B | 243.38B | 268.95B |
| Gross profit | 90.83B | 111.22B | 97.01B | 115.31B | 83.99B | 102.86B |
| Selling & admin expenses | 46.51B | 60.58B | 73.88B | 80.29B | 63.36B | 60.33B |
| Research & development | 14.93B | 15.00B | 17.10B | 15.48B | 18.96B | 22.53B |
| Operating profit | 28.47B | 34.99B | 5.37B | 20.16B | -848.00M | 19.62B |
| Pretax profit | 18.47B | 50.23B | 23.92B | 23.88B | 31.36B | 22.31B |
| Tax | 6.85B | 8.87B | 5.55B | 8.46B | 7.17B | 12.80B |
| Net profit | 11.97B | 42.38B | 20.61B | 15.63B | 23.50B | 10.44B |
| Basic EPS | 5 | 19 | 9 | 7 | 11 | 4 |
| Diluted EPS | 5.20 | 18.00 | 8.72 | 5.92 | 10.40 | 3.68 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 270.27B | 462.92B | 643.36B | 638.54B | 697.97B | 752.86B | 674.05B | 610.77B |
| Cash & ST investments | 203.17B | 363.22B | 483.45B | 455.09B | 524.47B | 571.03B | 428.09B | 316.89B |
| Inventory | 8.53B | 14.86B | 27.86B | 30.09B | 28.55B | 25.46B | 18.89B | 18.91B |
| Total assets | 965.08B | 1.31T | 1.69T | 1.70T | 1.75T | 1.76T | 1.80T | 1.91T |
| Total current liabilities | 207.67B | 241.87B | 377.36B | 383.78B | 385.35B | 421.51B | 435.35B | 476.40B |
| Short-term debt | 22.47B | 7.92B | 17.51B | 13.84B | 17.93B | 34.87B | 26.51B | 32.54B |
| Long-term debt | 111.83B | 120.28B | 135.72B | 132.50B | 149.09B | 141.78B | 208.14B | 231.77B |
| Total liabilities | 349,674,000,000.00 | 433,334,000,000.00 | 606,584,000,000.00 | 613,360,000,000.00 | 630,123,000,000.00 | 652,230,000,000.00 | 714,121,000,000.00 | 783,300,000,000.00 |
| Total equity | 615.40B | 879.65B | 1.08T | 1.08T | 1.12T | 1.11T | 1.09T | 1.13T |
| Retained earnings | 257.89B | 406.29B | 554.92B | 563.56B | 599.03B | 597.90B | 645.48B | 708.38B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 674.05B | 686.07B | 646.62B | 612.22B | 610.77B | 724.85B |
| Cash & ST investments | 428.09B | 416.42B | 373.57B | 338.11B | 316.89B | 385.70B |
| Inventory | 18.89B | -- | -- | -- | 18.91B | -- |
| Total assets | 1.80T | 1.85T | 1.88T | 1.88T | 1.91T | 1.96T |
| Total current liabilities | 435.35B | 473.63B | 444.14B | 459.81B | 476.40B | 532.26B |
| Short-term debt | 26.51B | 24.58B | 26.29B | 24.66B | 32.54B | 30.61B |
| Long-term debt | 208.14B | 207.51B | 255.31B | 238.09B | 231.77B | 235.92B |
| Total liabilities | 714,121,000,000.00 | 753,766,000,000.00 | 772,095,000,000.00 | 772,371,000,000.00 | 783,300,000,000.00 | 848,215,000,000.00 |
| Total equity | 1.09T | 1.09T | 1.11T | 1.11T | 1.13T | 1.11T |
| Retained earnings | 645.48B | 647.54B | 666.78B | 682.83B | 708.38B | 701.92B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 150.98B | 180.61B | 231.79B | 142.76B | 199.75B | 182.59B | 163.51B | 76.21B |
| Depreciation & amortization | 37.08B | 42.43B | 47.91B | 48.07B | 46.94B | 44.50B | 42.46B | 47.12B |
| Free cash flow | 101.33B | 135.22B | 188.60B | 89.44B | 165.40B | 149.66B | 77.54B | -50.72B |
| Dividends paid | -- | -- | -- | 0 | 0 | -17.95B | -29.08B | -33.73B |
| Stock buybacks / issuance | -10.52B | 91.51B | -598.00M | -61.12B | -74.74B | -87.90B | -86.65B | -6.60B |
| Ending cash balance | 198.49B | 345.98B | 356.47B | 227.35B | 229.51B | 286.42B | 189.27B | 173.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 27.52B | 20.67B | 10.10B | 36.03B | 9.41B | 22.95B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -58.45B | 20.67B | 10.10B | 36.03B | -117.53B | 22.95B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 189.27B | 224.58B | 175.44B | 170.52B | 173.57B | 185.50B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE % | 20.42 | 23.93 | 17.76 | 6.57 | 7.48 | 8.07 | 12.97 | 10.23 |
| ROA % | 10.41 | 13.10 | 10.01 | 3.66 | 4.21 | 4.53 | 7.26 | 5.70 |
| ROIC % | 9.89 | 11.72 | 9.33 | 6.97 | 7.50 | 7.88 | 9.87 | 3.56 |
| 5-year avg ROE % | 24.99 | 24.25 | 19.91 | 17.71 | 15.23 | 12.76 | 10.57 | 9.06 |
| EBIT margin % | 26.91 | 33.71 | 23.71 | 9.40 | 12.22 | 12.70 | 16.57 | 13.60 |
| FCF / sales % | 26.89 | 26.53 | 26.29 | 10.48 | 19.04 | 15.90 | 7.78 | -- |
| Current ratio | 1.30 | 1.91 | 1.70 | 1.66 | 1.81 | 1.79 | 1.55 | 1.28 |
| Quick ratio | 1.14 | 1.72 | 1.45 | 1.40 | 1.57 | 1.55 | 1.28 | 1.05 |
| Debt / assets | 27.28 | 19.50 | 19.35 | 18.62 | 19.76 | 20.84 | 24.57 | 26.56 |
| LT debt / equity | 22.72 | 18.45 | 17.49 | 17.16 | 17.95 | 17.31 | 21.94 | 23.49 |
| Interest coverage | 19.54 | 33.17 | 37.99 | 3.89 | 6.25 | 6.67 | 17.20 | 14.21 |
| Revenue CAGR (3Y) % | 55.03 | 47.67 | 42.05 | 31.30 | 19.45 | 9.48 | 5.31 | 5.62 |
| Net income CAGR (3Y) % | 7.14 | 50.69 | 32.94 | -10.86 | -21.32 | -19.00 | 27.86 | 12.49 |
| FCF CAGR (3Y) % | 30.12 | 27.46 | 25.26 | -4.08 | 6.95 | -7.42 | -4.65 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 12.97 | 15.20 | 12.63 | 9.10 | 10.23 | 7.11 |
| ROA % | 7.26 | 8.17 | 6.88 | 4.97 | 5.70 | 3.85 |
| ROIC % | 9.87 | 12.97 | 8.19 | 5.20 | 3.56 | 2.12 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 16.57 | 18.14 | 15.52 | 12.45 | 13.60 | 10.63 |
| FCF / sales % | 7.78 | 6.45 | 4.27 | 0.82 | -- | -- |
| Current ratio | 1.55 | 1.45 | 1.46 | 1.33 | 1.28 | 1.36 |
| Quick ratio | 1.28 | 1.36 | 1.36 | 1.24 | 1.05 | 1.28 |
| Debt / assets | 24.57 | 22.90 | 27.27 | 25.27 | 26.56 | 25.41 |
| LT debt / equity | 21.94 | 20.47 | 24.73 | 22.90 | 23.49 | 22.49 |
| Interest coverage | 17.20 | 21.59 | 15.74 | 12.59 | 14.21 | 11.50 |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Alibaba E-commerce Group76.54%
Artificial intelligence (AI) Cloud and Compute Services18.01%
All Others10.71%
Artificial intelligence (AI) Labs and Applications1.24%
Unallocated0.29%
Quote time 2026-09-04 20:02:23
For reference only, not investment advice.